Answers are grounded in this paper and cite their sources.
Chromosomal mosaicism detected prenatally poses significant challenges for prognosis and genetic counseling, especially when involving rare chromosomes or discordant findings between fetus and placenta. We report a unique case of resolving mosaic trisomy 2 in the fetus with discordant mosaic monosomy 6 confined to the placenta, followed by a favorable outcome. A 32-year-old woman underwent amniocentesis at 20 weeks due to high-risk second-trimester maternal serum screening for Down syndrome. Initial CNV-seq revealed mosaic trisomy 2 (40%) and a 0.88 Mb deletion at 13q14.2q14.3 (seq[hg19]del(13)(q14.2q14.3)chr13:g.50760000_51640000del) of uncertain significance. Karyotyping was normal. Repeat amniocentesis at 24 weeks showed the trisomy 2 mosaicism had decreased to 2% by FISH (approximately 8% by concurrent CNV-seq), while the 13q deletion persisted. Prenatal ultrasounds showed only mild soft markers. The pregnancy continued to 39 + weeks, delivering a healthy male infant (birth weight 2.54 kg, Apgar 10). Postnatal analysis of 10 placental sites revealed mosaic monosomy 6 (5–10%) in 4 sites, while the 13q deletion was present in all placental sites and cord blood. No chromosome 2 or 6 abnormalities were detected in cord blood. STR analysis excluded maternal cell contamination, and ROH analysis excluded uniparental disomy. This case demonstrates that mosaic trisomy 2 can resolve spontaneously in utero and may be associated with a favorable postnatal outcome despite discordant feto-placental aneuploidy (trisomy 2 in fetus, monosomy 6 in placenta). It underscores the dynamic nature of mosaicism, the importance of multimodal diagnostic approaches, and the need for cautious, informed genetic counseling.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: